Literature DB >> 1732029

Progress in pediatric extracorporeal membrane oxygenation.

B P Fuhrman1, H J Dalton.   

Abstract

Prolonged complete support of the circulation and of gas exchange can be achieved by extracorporeal membrane oxygenation (ECMO) in infants and children with potentially reversible, albeit life-threatening, disease. This allows lung rest or cardiac rest at times when dependence in those organs would be physiologically expensive. Although ECMO has no intrinsic healing powers, pediatric hearts and lungs exhibit tremendous recuperative power once the cycle of injury, inefficient performance, abuse, and secondary injury can be broken. Recent advances in technology, although impressive, do not explain the rapid growth of clinical interest in ECMO. Most recent progress in ECMO derives from refinement of clinical practices and the application of this technology to new patient populations. ECMO is not itself an experiment. It is the application of ECMO that is experimental.

Entities:  

Mesh:

Year:  1992        PMID: 1732029

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  3 in total

Review 1.  An overview of extracorporeal membrane oxygenation therapy.

Authors:  M B Madonna; R M Arensman
Journal:  Indian J Pediatr       Date:  1997 May-Jun       Impact factor: 1.967

2.  Perioperative mechanical circulatory support in children with critical heart disease.

Authors:  Paul A Checchia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

3.  In vitro characterization and performance testing of the ension pediatric cardiopulmonary assist system.

Authors:  George M Pantalos; Tim Horrell; Tracey Merkley; Sarina Sahetya; Jeff Speakman; Greg Johnson; Mark Gartner
Journal:  ASAIO J       Date:  2009 May-Jun       Impact factor: 2.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.